Chile on Wednesday became the latest country to give emergency approval to China’s CoronaVac vaccine as it battles the coronavirus epidemic which has claimed more than 17,500 lives in the country to date.
CoronaVac was developed by China’s Sinovac firm and has been approved for emergency use in Brazil, China, Indonesia and Turkey.
Chile joined the small club on Wednesday when its ISP public health institute gave the go-ahead. The country hopes to receive 10 million doses of the vaccine, adding to the Pfizer/Biontech jab that it has already started distributing.
ISP director Heriberto Garcia told reporters Wednesday the approval was given after trials showed CoronaVac was safe and 78 percent effective in preventing infection if given in two doses to people aged between 18 and 60.Read:New tech aims to tackle ‘disseminated intravascular coagulation’ blood disorder
Earlier this month, Brazil said its own tests had shown CoronaVac to be 50 percent effective.
Panama rolled out its own vaccination campaign Wednesday with nurse Violeta Gaona receiving the first shot.
The country has the highest infection rate in Central America, with some 300,000 cases and more than 4,800 deaths.
Some countries have been having trouble laying their hands on enough vaccine doses, and the World Health Organization has said rich countries are hogging most of the doses as it warned of a “catastrophic moral failure” if poor countries are left behind.Read:Borderline personality disorder: Don’t ignore it
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Read:Research finds new link between personality and risk of death
Chile approves Chinese coronavirus vaccine (2021, January 20)
retrieved 20 January 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.